Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and tolerability of XL999 in adults with advanced solid tumors.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Symphony Evolution, Inc.
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT07671846 · Cancer
NCT06689488 · Lung Cancer
NCT06274047 · Androgen Axis Suppression, Prostatectomy, and more
NCT06079671 · Locally Advanced Cervical Cancer
Case Western Reserve University, Univserzity Hospitals of Cleveland
Cleveland, Ohio
Cancer Therapy and Research Center, Institute for Drug Development
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions